Home » Newsletters » The Carlat Addiction Treatment Report

The Carlat Addiction Treatment Report

Alcohol Addiction (September/October) | 2019

View Archived Issues

CME Post-Test - Alcohol Addiction, CATR, September/October 2019

October 2, 2019

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME credit. Read More

Primer: Evidence-Based Psychosocial Interventions for Substance Use Disorders

October 2, 2019

Psychosocial interventions for substance use disorders include drug counseling, medical management, cognitive behavioral therapy, motivational interviewing, contingency management, the community reinforcement approach, and twelve-step facilitation Read More

Treating Alcohol Use Disorder

October 2, 2019

Albert J. Arias, MD, MS

We have five main medications to offer patients with alcohol use disorder: acamprosate, disulfiram, gabapentin, naltrexone (PO or IM), and topiramate. The combination of naltrexone and gabapentin may work better than either of these two medications alone. Read More

Biomarkers of Alcohol Use

October 2, 2019

The newer biomarkers of alcohol use include carbohydrate-deficient transferrin; ethyl glucuronide and ethyl sulfate; and phosphatidylethanol. Read More

N-acetylcysteine Not Effective for Cannabis Use Disorder in Adults

October 2, 2019

Brian Frankel, MD

N-acetylcysteine (NAC), an over-the counter supplement related to the amino acid cysteine, has been shown to have some efficacy in adolescents with cannabis use disorder (CUD). This current study explores whether NAC can be effective for CUD in adult patients as well. Read More